Stephens Inc Charles River Laboratories International, Inc. Transaction History

Stephens Inc

$6.77 Billion
Q3 2024

A detailed history of Stephens Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Stephens Inc holds 5,463 shares of CRL stock, worth $1.09 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,463

Previous 2,408 126.87%

Holding current value

$1.09 Million

Previous $497,000 116.5%

% of portfolio

0.02%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$187.96 - $245.29 $574,217 - $749,360	3,055 Added 126.87%	5,463 $1.08 Million
Q2 2024 Aug 06, 2024	BUY	$206.39 - $268.73 $16,304 - $21,229	79 Added 3.39%	2,408 $497,000
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $75,912 - $101,989	373 Added 19.07%	2,329 $631,000
Q4 2023 Feb 13, 2024	BUY	$164.52 - $238.84 $15,300 - $22,212	93 Added 4.99%	1,956 $462,000
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $6,222 - $6,963	32 Added 1.75%	1,863 $365,000
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $11,022 - $12,615	60 Added 3.39%	1,831 $384,000
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $44,902 - $60,821	234 Added 15.22%	1,771 $357,000
Q4 2022 Jan 25, 2023	SELL	$197.11 - $250.07 $29,960 - $38,010	-152 Reduced 9.0%	1,537 $335,000
Q3 2022 Nov 02, 2022	SELL	$182.44 - $250.54 $41,596 - $57,123	-228 Reduced 11.89%	1,689 $332,000
Q2 2022 Aug 03, 2022	BUY	$204.13 - $302.4 $36,335 - $53,827	178 Added 10.24%	1,917 $410,000
Q1 2022 May 04, 2022	SELL	$255.51 - $362.11 $15,330 - $21,726	-60 Reduced 3.34%	1,739 $494,000
Q4 2021 Mar 07, 2022	BUY	$351.38 - $448.68 $457,848 - $584,630	1,303 Added 262.7%	1,799 $678,000
Q3 2021 Oct 27, 2021	BUY	$372.64 - $458.3 $184,829 - $227,316	496 New	496 $205,000

Others Institutions Holding CRL

# of Institutions

698

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account